Patents by Inventor Christophe C. Parsy

Christophe C. Parsy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11730748
    Abstract: The present invention relates to Compounds of Formula (I) or Formula (II): or a pharmaceutically acceptable salt, solvate or enantiomer thereof, wherein A, B, R1, R2, R3, R4, Q and V are as defined herein. The present invention also relates to pharmaceutical compositions comprising a Compound of Formula (I) or Formula (II) and to their use in therapy.
    Type: Grant
    Filed: November 24, 2020
    Date of Patent: August 22, 2023
    Assignee: MSD International GMBH
    Inventors: Cyril B. Dousson, David Dukhan, Christophe C. Parsy, Stephane L. Bogen
  • Publication number: 20210205339
    Abstract: The present invention relates to Compounds of Formula (I) or Formula (II): or a pharmaceutically acceptable salt, solvate or enantiomer thereof, wherein A, B, R1, R2, R3, R4, Q and V are as defined herein. The present invention also relates to pharmaceutical compositions comprising a Compound of Formula (I) or Formula (II) and to their use in therapy.
    Type: Application
    Filed: November 24, 2020
    Publication date: July 8, 2021
    Applicant: MSD International GMBH
    Inventors: Cyril B. Dousson, David Dukhan, Christophe C. Parsy, Stephane L. Bogen
  • Patent number: 10815264
    Abstract: The present application relates to novel nucleoside derivatives of formula (I) as claimed in claim 1, pharmaceutical compositions comprising the compounds, processes of preparation thereof, and methods of use thereof for treating cancer.
    Type: Grant
    Filed: May 25, 2016
    Date of Patent: October 27, 2020
    Assignee: Southern Research Institute
    Inventors: Cyril B. Dousson, David Dukhan, Jean-Laurent Paparin, Christophe C. Parsy
  • Publication number: 20190365788
    Abstract: The present invention relates to Compounds of Formula (I) or Formula (II) or a pharmaceutically acceptable salt, solvate or enantiomer thereof, wherein A, B, R1, R2, R3, R4, Q and V are as defined herein. The present invention also relates to pharmaceutical compositions comprising a Compound of Formula (I) or Formula (II) and to their use in therapy.
    Type: Application
    Filed: November 15, 2017
    Publication date: December 5, 2019
    Applicant: IDENIX PHARMACEUTICALS LLC
    Inventors: Cyril Dousson, David Dukhan, Christophe C. Parsy, Stephane L. Bogen